Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07401901 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes

Study acronym: ELEVATE
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jul 15, 2026 to Oct 15, 2026 Primary completion pushed from Nov 4, 2027 to Dec 4, 2027 · Completion pushed from Feb 28, 2028 to Mar 29, 2028 · Study sites: 20 to 21 · 1 morev3 Show 4 more changesShow less
    • Primary completion pushed from Nov 4, 2027 to Dec 4, 2027
    • Completion pushed from Feb 28, 2028 to Mar 29, 2028
    • Study sites: 20 to 21
    • Eligibility criteria expanded, about 27 words

    See this version in full on ClinicalTrials.gov ↗

  2. Changed Sponsor changed: Medtronic Diabetes to Medtronic MiniMed, Inc.
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to evaluate the safety and the effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery system, named MiniMed NMX8 system (referred also to as NMX8 system), in comparison with other commercially available AID systems (Automated insulin delivery) in adult patients with Type 1 diabetes not achieving target clinical outcomes.
Trial Details
NCT Number NCT07401901
Lead Sponsor Medtronic MiniMed, Inc.
Conditions Type 1 Diabetes (T1D)
Enrollment 230 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov